(Q44823107)

6 December 2017

Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus (English)

1 reference

6 December 2017

1 reference

psammomys obesus

1 reference

1 reference

Monika Zoltowska

1

1 reference

6 December 2017

Edgard Delvin

2

1 reference

6 December 2017

Ehud Ziv

3

1 reference

6 December 2017

Noel Peretti

4

1 reference

6 December 2017

Manon Chartré

5

1 reference

6 December 2017

Emile Levy

6

1 reference

6 December 2017

1 January 2004

1 reference

6 December 2017

1 reference

6 December 2017

39

1 reference

6 December 2017

1

1 reference

6 December 2017

81-85

1 reference

https://scigraph.springernature.com/pub.10.1007/s11745-004-1205-7

6 December 2017

0 references

cites work

Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

1 reference

12 December 2020

Glycated low density lipoproteins modify platelet properties: a compositional and functional study

1 reference

12 December 2020

Lipogenesis in the sand rat (Psammomys obesus)

1 reference

12 December 2020

Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs

1 reference

12 December 2020

Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages

1 reference

12 December 2020

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

1 reference

12 December 2020

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

1 reference

12 December 2020

Mechanisms of hypercholesterolaemia in glycogen storage disease type I: defective metabolism of low density lipoprotein in cultured skin fibroblasts

1 reference

12 December 2020

A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins

1 reference

12 December 2020

Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition

1 reference

12 December 2020

Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.

1 reference

12 December 2020

Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats

1 reference

12 December 2020

Management of patients with diabetic hyperlipidemia

1 reference

12 December 2020

Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients

1 reference

12 December 2020

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

12 December 2020

Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia

1 reference

12 December 2020

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

1 reference

12 December 2020

Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B.

1 reference

12 December 2020

Diabetes and advanced glycation endproducts

1 reference

12 December 2020

Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages

1 reference

12 December 2020

Vascular responses to alpha-adrenergic stimulation and depolarization are enhanced in insulin-resistant and diabetic Psammomys obesus

1 reference

12 December 2020

Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products

1 reference

12 December 2020

Advanced glycation end products and diabetic complications

1 reference

12 December 2020

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

1 reference

12 December 2020

Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects

1 reference

12 December 2020

Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes

1 reference

12 December 2020

Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis

1 reference

12 December 2020

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

12 December 2020

Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients

1 reference

12 December 2020

Central role of RAGE-dependent neointimal expansion in arterial restenosis

1 reference

12 December 2020

Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation

1 reference

12 December 2020

Development of noninvasive and quantitative methodologies for the assessment of chronic ulcers and scars in humans

1 reference

12 December 2020

10.1007/S11745-004-1205-7

Identifiers

DOI

1 reference

6 December 2017

1 reference